<\/span><\/h3>\nNg\u01b0\u1eddi ta kh\u00f4ng bi\u1ebft li\u1ec7u Afatinib c\u00f3 trong s\u1eefa m\u1eb9 hay kh\u00f4ng. Afatinib c\u00f3 m\u1eb7t trong s\u1eefa c\u1ee7a chu\u1ed9t \u0111ang cho con b\u00fa \u1edf n\u1ed3ng \u0111\u1ed9 cao h\u01a1n 80-150 l\u1ea7n so v\u1edbi n\u1ed3ng \u0111\u1ed9 t\u00ecm th\u1ea5y trong huy\u1ebft t\u01b0\u01a1ng t\u1eeb 1 \u0111\u1ebfn 6 gi\u1edd sau khi qu\u1ea3n l\u00fd. B\u1edfi v\u00ec nhi\u1ec1u lo\u1ea1i thu\u1ed1c c\u00f3 trong s\u1eefa m\u1eb9 v\u00e0 v\u00ec kh\u1ea3 n\u0103ng \u0111\u1ed1i v\u1edbi c\u00e1c ph\u1ea3n \u1ee9ng c\u00f3 h\u1ea1i nghi\u00eam tr\u1ecdng \u1edf tr\u1ebb b\u00fa m\u1eb9 t\u1eeb Afatinib, n\u00ean \u0111\u01b0a ra quy\u1ebft \u0111\u1ecbnh xem ng\u1eebng \u0111i\u1ec1u d\u01b0\u1ee1ng ho\u1eb7c ng\u1eebng thu\u1ed1c, c\u00f3 t\u00ednh \u0111\u1ebfn t\u1ea7m quan tr\u1ecdng c\u1ee7a thu\u1ed1c \u0111\u1ed1i v\u1edbi ng\u01b0\u1eddi m\u1eb9.<\/span><\/p>\n<\/span>S\u1eed d\u1ee5ng cho tr\u1ebb em:<\/b><\/strong><\/span><\/span><\/h3>\nT\u00ednh an to\u00e0n v\u00e0 hi\u1ec7u qu\u1ea3 c\u1ee7a Afatinib \u1edf b\u1ec7nh nhi ch\u01b0a \u0111\u01b0\u1ee3c thi\u1ebft l\u1eadp.<\/span><\/p>\n<\/span>S\u1eed d\u1ee5ng cho ng\u01b0\u1eddi gi\u00e0:<\/b><\/strong><\/span><\/span><\/h3>\nTrong s\u1ed1 3.865 b\u1ec7nh nh\u00e2n trong c\u00e1c nghi\u00ean c\u1ee9u l\u00e2m s\u00e0ng c\u1ee7a Afatinib, 32% b\u1ec7nh nh\u00e2n t\u1eeb 65 tu\u1ed5i tr\u1edf l\u00ean, trong khi 7% t\u1eeb 75 tu\u1ed5i tr\u1edf l\u00ean. Kh\u00f4ng c\u00f3 s\u1ef1 kh\u00e1c bi\u1ec7t t\u1ed5ng th\u1ec3 v\u1ec1 an to\u00e0n \u0111\u01b0\u1ee3c quan s\u00e1t th\u1ea5y gi\u1eefa b\u1ec7nh nh\u00e2n t\u1eeb 65 tu\u1ed5i tr\u1edf l\u00ean v\u00e0 b\u1ec7nh nh\u00e2n tr\u1ebb h\u01a1n. 39% trong s\u1ed1 345 b\u1ec7nh nh\u00e2n 65 tu\u1ed5i tr\u1edf l\u00ean v\u00e0 4% t\u1eeb 75 tu\u1ed5i tr\u1edf l\u00ean. Kh\u00f4ng c\u00f3 s\u1ef1 kh\u00e1c bi\u1ec7t t\u1ed5ng th\u1ec3 v\u1ec1 hi\u1ec7u qu\u1ea3 \u0111\u01b0\u1ee3c quan s\u00e1t th\u1ea5y gi\u1eefa b\u1ec7nh nh\u00e2n 65 tu\u1ed5i tr\u1edf l\u00ean v\u00e0 b\u1ec7nh nh\u00e2n tr\u1ebb h\u01a1n.<\/span><\/p>\n<\/span>Ph\u1ee5 n\u1eef v\u00e0 nam gi\u1edbi trong \u0111\u1ed9 tu\u1ed5i sinh s\u1ea3n:<\/b><\/strong><\/span><\/span><\/h3>\nT\u01b0 v\u1ea5n cho b\u1ec7nh nh\u00e2n v\u1ec1 k\u1ebf ho\u1ea1ch v\u00e0 ph\u00f2ng ng\u1eeba mang thai. T\u01b0 v\u1ea5n cho b\u1ec7nh nh\u00e2n n\u1eef v\u1ec1 sinh s\u1ea3n ti\u1ec1m n\u0103ng s\u1eed d\u1ee5ng bi\u1ec7n ph\u00e1p tr\u00e1nh thai hi\u1ec7u qu\u1ea3 cao trong khi \u0111i\u1ec1u tr\u1ecb v\u1edbi Afatinib, v\u00e0 \u00edt nh\u1ea5t 2 v\u00e0i tu\u1ea7n sau li\u1ec1u Afatinib cu\u1ed1i c\u00f9ng. Khuy\u00ean b\u1ec7nh nh\u00e2n li\u00ean h\u1ec7 v\u1edbi nh\u00e0 cung c\u1ea5p d\u1ecbch v\u1ee5 ch\u0103m s\u00f3c s\u1ee9c kh\u1ecfe c\u1ee7a h\u1ecd n\u1ebfu h\u1ecd c\u00f3 thai, ho\u1eb7c n\u1ebfu nghi ng\u1edd c\u00f3 thai khi d\u00f9ng Afatinib.<\/span><\/p>\n<\/span>Suy th\u1eadn:<\/b><\/strong><\/span><\/span><\/h3>\n